Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-31 @ 2:10 PM
Study NCT ID:
NCT07076212
Status:
RECRUITING
Last Update Posted:
2025-11-12
First Post:
2025-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma
Sponsor:
Medical University of South Carolina
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2028-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-11
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-14
First Submit QC Date:
None
Study First Post Date:
2025-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-10
Last Update Post Date:
2025-11-12
Last Update Post Date Type:
ESTIMATED